Metropolis Healthcare Limited (NSE:METROPOLIS)
1,938.80
+0.10 (0.01%)
Jul 21, 2025, 3:30 PM IST
Metropolis Healthcare Revenue
In the fiscal year ending March 31, 2025, Metropolis Healthcare had annual revenue of 13.31B INR with 10.23% growth. Metropolis Healthcare had revenue of 3.45B in the quarter ending March 31, 2025, with 4.32% growth.
Revenue
13.31B
Revenue Growth
+10.23%
P/S Ratio
7.55
Revenue / Employee
3.09M
Employees
4,313
Market Cap
100.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 13.31B | 1.23B | 10.23% |
Mar 31, 2024 | 12.08B | 594.99M | 5.18% |
Mar 31, 2023 | 11.48B | -801.26M | -6.52% |
Mar 31, 2022 | 12.28B | 2.30B | 23.08% |
Mar 31, 2021 | 9.98B | 1.42B | 16.53% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Glenmark Pharmaceuticals | 134.35B |
Metropolis Healthcare News
- 12 days ago - Metropolis Healthcare eyes double-digit growth as B2C gains traction - Business Upturn
- 14 days ago - Metropolis Healthcare shares rise over 2% today as specialty and TruHealth segments post strong Q1 growth - Business Upturn
- 4 weeks ago - Dr Lal PathLabs, Metropolis Healthcare shares decline as Amazon Diagnostics enters market - Business Upturn
- 3 months ago - Metropolis Healthcare to acquire Dr. Ahujas’ Pathology & Imaging Centre for Rs 35 crore - Business Upturn
- 3 months ago - Metropolis Healthcare posts 10% YoY revenue growth in Q4 FY25, wellness segment drives performance - Business Upturn
- 3 months ago - Stocks hitting 52-week low today, April 1: Titan Company, Tata Elxsi, UCO Bank, Birlasoft, Metropolis Healthcare and more - Business Upturn
- 5 months ago - Metropolis Healthcare to acquire scientific pathology’s business in Agra for up to Rs 83 Crore - Business Upturn
- 5 months ago - Metropolis Health shares jump 3% as revenue rises 11% YoY in Q3 - Business Upturn